Hu et al. showed that PRMT2 is recruited to the Bcl-2 promoter and generates H3R8 dimethylation, which maintains Bcl-2 gene expression by inducing STAT3 accessibility, thereby promoting cell proliferation in HCC. This evidence concerns the gene PRMT2 and hepatocellular carcinoma.